Japanese scientists conducted a clinical trial using stem cells to treat severe corneal damage. The trial involved four ...

A radical stem cell transplant has significantly improved the blurry vision of three people with severe damage to their ...

Researchers successfully tested the safety and preliminary efficacy of stem-cell-derived corneal implants, showing promise ...

Fuchs' dystrophy is an inherited condition affecting the cornea that can cause impaired vision and discomfort, but treatments are available.

A revolutionary stem cell treatment restored the vision of three people by repairing their damaged corneas. Initially, four ...

Two years after surgery, three patients experienced improved corneal transparency with no serious side effects.

When this essential source of rejuvenation is depleted — a condition known as limbal stem-cell deficiency (LSCD) — scar ...

Three individuals with vision disabilities experienced eyesight improvements after receiving stem-cell transplants targeting ...

A startup company based at Upstate Medical University won the top prize at the Biotech Innovation Pitch competition held Oct.

DUB Therapeutics, an Upstate Medical University–based startup company, won the $10,000 Alan W. Rothschild Innovation Award at ...

In early November, researchers at Osaka University in Japan published groundbreaking findings in the scientific journal The ...